« A New Kind of Search Experience | Main | Make your search engine seem psychic »

January 31, 2011

Great new tool for Pharmaceutical researchers

Topic_Explorer Our partners over at Raritan Technologies Inc. have recently released a great tool they developed using the  Lexalytics, Inc. Salence toolkit. The product, Topic Explorer, provides a way for users to dig through content and explore concepts from Raritan's extensive knowledgebase of medical terminology, augmented by the text analytics capabilities provided by Lexalytics. Many of you will remember Lexalytics as the company that provided great sentiment analysis in the original FAST ESP product prior to the acquisition by Microsoft.

Raritan co-founder Ted Sullivan gives a great video demo of the product you should see.

What's really great about Topic Explorer is that it isn't limited to just pharma. With the right taxonomy, it can be a great research tool for just about any vertical - risk management, eDiscovery, patent research, and more.

Topic Explorer is a search technology neutral product, so it will work with your current solution whether you're using Lucene/Solr or a popular commercial technolgy. Contact Raritan at 908-668-8181 Extentsion 110. Tell them you read it here! 

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c84cf53ef0148c832df23970c

Listed below are links to weblogs that reference Great new tool for Pharmaceutical researchers:

Comments

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.